ArticleLe infezioni in medicina2021
Article in Le infezioni in medicina, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.
- On the usage of artificial intelligence in leprosy care: A systematic literature review.PLoS computational biology · 2025Pooled it
- Health Education Method on Leprosy Prevention: Integrative Review.Archives of Razi Institute · 2024Pooled it
- Quality of life, stigma, and mental health, in individuals affected by leprosy: a cross-sectional study.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2026Article
- Lessons From the Past, Hope for the Future: A Qualitative Study on the Lives of Leprosy-Affected Residents of a Leprosy Settlement in Malaysia.Qualitative health research · 2026Article
- Article
- Unmasking oral health stigma: a qualitative scoping review.BMC oral health · 2025Article
- Leprosy elimination: are we winning the fight or losing focus?Annals of medicine · 2025Article
- Burden of Disability, Poverty, and Unmet Needs Among Persons Affected by Hansen's Disease: Insights from Antulya Nagar, Pune- A Cross-Sectional Study.Journal of pharmacy & bioallied sciences · 2025Article
- 4,000-year-old Mycobacterium lepromatosis genomes from Chile reveal long establishment of Hansen's disease in the Americas.Nature ecology & evolution · 2025Article
- Hansen's disease patient in Ohio successfully treated with a monthly rifampin, minocycline, and moxifloxacin regimen: a case report.ASM case reports · 2025Article
- Barriers to leprosy elimination in Bolivia: Exploring perspectives and experiences of medical professionals and leprosy patients-A phenomenological study.PLoS neglected tropical diseases · 2025Article
- "The general public will never truly know what it feels like": Exploring the Lived Experiences of Persons Affected by Leprosy in Sindh, Pakistan - A qualitative study.PLOS mental health · 2025Article
- Exploring the Neurological Manifestations of Leprosy: Clinical Insights and Implications.Cureus · 2025Review
- Beyond Classic Leprosy: Exploring Atypical Manifestations and Their Diagnostic Challenges.Cureus · 2024Article
- Exploring the Chemical Space of Mycobacterial Oxidative Phosphorylation Inhibitors Using Molecular Modeling.ChemMedChem · 2024Review
- Validity and reliability of local endemic language version of the SARI Sigma Scale questionnaire for assessing stigma in leprosy patients.Frontiers in public health · 2024Article
- Leprosy with subsequent type 2 reaction masquerading as cutaneous tuberculosis: a case report and diagnostic pitfalls in a non-endemic area.Le infezioni in medicina · 2024Article
- Editorial: New insights in leprosy (Hansen's disease).Frontiers in medicine · 2024Article
- Artificial Intelligence on Diagnostic Aid of Leprosy: A Systematic Literature Review.Journal of clinical medicine · 2023Review
- Leprosy among children in an area without primary health care coverage in Caratateua Island, Brazilian Amazon.Frontiers in medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article aims to investigate about the social stigma and the prejudice of society towards the patients with leprosy, but also to understand how this infectious disease has largely influenced human lifestyle and evolution analyzing the evolution of its treatments from past empirical treatments to actual multidrug therapy (MDT). References on leprosy were extensively searched in literature using PubMed, Web of Science, Medline, Springer link and Elsevier's (EMBASE.com) databases, but also in medical, religious and archaeological books. Leprosy's spread all around the world following human paths of migration from the African Continent to the Asian one and to Europe, instead its appearance in the New Continent is more recent. Wars, unhygienic conditions, social and health inequality created conditions for its spread since prehistorical times, and existing health disparities contributed to unequal morbidity and mortality, before its gradual decline after the Middle Ages due to the raise of other worse pandemics. Starting from Renaissance, a deeper knowledge on its pathophysiological mechanisms brought an increasingly advanced combined surgical and pharmacological treatment, but still in modern times many efforts have been made to erase its social stigma, changing its name in "Hansen's disease" included.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.